Yes: Gaucher disease treatment used to be limited to enzyme replacement therapy (ert)with cerazyme as the only product. Since there is now a oral ert product called Miglustat as well as competing ert products vpriv (velaglucerase alfa) and elylyso. In addition, there is substrate reduction therapy (srt) agents in the pipeline that are under investigation at the moment.
Answered 1/28/2015
4.9k views
A doctor has provided 1 answer
12 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question